Temsirolimus in the treatment of advanced renal cell carcinoma
Temsirolimus is a novel inhibitor of mammalian target of rapamycin (mTOR), which is a central regulator of the response of tumour cells to growth and survival signals. When heavily pretreated patients with advanced solid tumours received intravenous (IV) temsirolimus over a broad dose range, antitum...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2011-12-01
|
| coleção: | Oncology Reviews |
| Assuntos: | |
| Acesso em linha: | http://oncologyreviews.org/index.php/or/article/view/142 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|